[go: up one dir, main page]

NO873727L - Fremgangsmaate for fremstilling av benzoksazoninforbindelser med terapeutisk aktivitet. - Google Patents

Fremgangsmaate for fremstilling av benzoksazoninforbindelser med terapeutisk aktivitet.

Info

Publication number
NO873727L
NO873727L NO873727A NO873727A NO873727L NO 873727 L NO873727 L NO 873727L NO 873727 A NO873727 A NO 873727A NO 873727 A NO873727 A NO 873727A NO 873727 L NO873727 L NO 873727L
Authority
NO
Norway
Prior art keywords
benzocsazone
relations
procedure
preparation
therapeutic activity
Prior art date
Application number
NO873727A
Other languages
English (en)
Other versions
NO873727D0 (no
NO168530C (no
NO168530B (no
Inventor
Friderich Eiden
Peter Gmeiner
Juergen Schuenemann
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of NO873727D0 publication Critical patent/NO873727D0/no
Publication of NO873727L publication Critical patent/NO873727L/no
Publication of NO168530B publication Critical patent/NO168530B/no
Publication of NO168530C publication Critical patent/NO168530C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO873727A 1986-09-08 1987-09-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser. NO168530C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863630539 DE3630539A1 (de) 1986-09-08 1986-09-08 Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten

Publications (4)

Publication Number Publication Date
NO873727D0 NO873727D0 (no) 1987-09-07
NO873727L true NO873727L (no) 1988-03-09
NO168530B NO168530B (no) 1991-11-25
NO168530C NO168530C (no) 1992-03-04

Family

ID=6309142

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873727A NO168530C (no) 1986-09-08 1987-09-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.

Country Status (29)

Country Link
US (1) US4859664A (no)
JP (1) JPS6377882A (no)
KR (1) KR910002566B1 (no)
CN (1) CN1020103C (no)
AR (1) AR243190A1 (no)
AT (1) ATA185987A (no)
AU (1) AU590443B2 (no)
BE (1) BE1002121A4 (no)
CH (1) CH675723A5 (no)
CS (1) CS621687A2 (no)
DD (1) DD275052A1 (no)
DE (1) DE3630539A1 (no)
DK (1) DK464487A (no)
ES (1) ES2013322A6 (no)
FI (1) FI88800C (no)
FR (1) FR2603587B1 (no)
GB (1) GB2194786B (no)
GR (1) GR871209B (no)
HU (1) HU203106B (no)
IL (1) IL83156A (no)
IT (1) IT1228437B (no)
NL (1) NL8701938A (no)
NO (1) NO168530C (no)
PL (1) PL154258B1 (no)
PT (1) PT85656B (no)
SE (1) SE8703343L (no)
SU (1) SU1565346A3 (no)
YU (1) YU46068B (no)
ZA (1) ZA876657B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE109483T1 (de) * 1988-06-01 1994-08-15 Smithkline Beecham Corp Alpha-adrenergische rezeptorantagonisten.
DE68919280T2 (de) * 1988-06-01 1995-03-23 Smithkline Beckman Corp Alpha-adrenergische Rezeptorantagonisten.
CA1320486C (en) * 1988-06-01 1993-07-20 John J. Lafferty .alpha. -adrenergic receptor antagonists
US4959360A (en) * 1988-06-01 1990-09-25 Smithkline Beecham Corporation α-adrenergic receptor antagonists
US4963547A (en) * 1988-06-01 1990-10-16 Smithkline Beecham Corporation Alpha-andrenergic receptor antagonists and use thereas
DE4102103A1 (de) * 1991-01-25 1992-08-20 Bayer Ag Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5248645A (en) * 1992-09-01 1993-09-28 Phillips Petroleum Company Ethylene oligomerization

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124583A (en) * 1964-03-10 Substituted derivatives of
US3118900A (en) * 1962-01-15 1964-01-21 Abbott Lab Substituted derivatives of 3-aza-6, 7-benzo-8-oxa-5-phenylbicyclo[3.3.1]-nonane
US3401166A (en) * 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
US3446820A (en) * 1967-04-03 1969-05-27 Rexall Drug Chemical Substituted benzoxazocines and intermediates
US3869475A (en) * 1973-04-05 1975-03-04 Yissum Res Dev Co 2,6-methano-benzoxacin compounds
JPS50106985A (no) * 1973-05-08 1975-08-22
US4100277A (en) * 1976-11-08 1978-07-11 American Home Products Corporation 4,1-Benzoxazonine derivatives and process therefor
DK344180A (da) * 1979-08-09 1981-02-10 Glaxo Group Ltd R fremgangsmaade til fremstilling af heterocycliske forbindelse

Also Published As

Publication number Publication date
IT8721436A0 (it) 1987-07-24
YU46068B (sh) 1992-12-21
FI873852L (fi) 1988-03-09
BE1002121A4 (fr) 1990-07-17
IT1228437B (it) 1991-06-17
NL8701938A (nl) 1988-04-05
ATA185987A (de) 1994-05-15
FI88800C (fi) 1993-07-12
GB2194786A (en) 1988-03-16
KR880003945A (ko) 1988-05-31
KR910002566B1 (ko) 1991-04-26
DK464487A (da) 1988-03-09
JPH0319236B2 (no) 1991-03-14
HUT50180A (en) 1989-12-28
CH675723A5 (no) 1990-10-31
CN87106267A (zh) 1988-04-13
DK464487D0 (da) 1987-09-07
DD275052A1 (de) 1990-01-10
IL83156A0 (en) 1987-12-31
JPS6377882A (ja) 1988-04-08
AR243190A1 (es) 1993-07-30
SU1565346A3 (ru) 1990-05-15
NO873727D0 (no) 1987-09-07
ES2013322A6 (es) 1990-05-01
US4859664A (en) 1989-08-22
GB8716668D0 (en) 1987-08-19
FI88800B (fi) 1993-03-31
DE3630539A1 (de) 1988-03-10
ZA876657B (en) 1988-03-08
HU203106B (en) 1991-05-28
FR2603587B1 (fr) 1991-02-01
NO168530C (no) 1992-03-04
PL154258B1 (en) 1991-07-31
CS621687A2 (en) 1990-09-12
AU590443B2 (en) 1989-11-02
SE8703343L (sv) 1988-03-09
PT85656A (en) 1987-10-01
GB2194786B (en) 1991-01-02
AU7816287A (en) 1988-03-10
FR2603587A1 (fr) 1988-03-11
NO168530B (no) 1991-11-25
IL83156A (en) 1992-12-01
PL267628A1 (en) 1989-06-12
PT85656B (pt) 1990-05-31
GR871209B (en) 1987-11-30
FI873852A0 (fi) 1987-09-07
SE8703343D0 (sv) 1987-08-28
CN1020103C (zh) 1993-03-17

Similar Documents

Publication Publication Date Title
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO875082D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO871588L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO871044L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO873835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO873727L (no) Fremgangsmaate for fremstilling av benzoksazoninforbindelser med terapeutisk aktivitet.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO168473C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner.